Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Chun SG, Hu C, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Kavadi VS, Narayan S, Iyengar P, Robinson C, Rothman J, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Chun SG, et al. Among authors: augspurger me. JAMA Oncol. 2024 Aug 1;10(8):1111-1115. doi: 10.1001/jamaoncol.2024.1841. JAMA Oncol. 2024. PMID: 38935373 Clinical Trial.
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Chun SG, et al. Among authors: augspurger me. J Clin Oncol. 2017 Jan;35(1):56-62. doi: 10.1200/JCO.2016.69.1378. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 28034064 Free PMC article. Clinical Trial.
Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.
Kachnic LA, Winter KA, Myerson RJ, Goodyear MD, Abitbol AA, Streeter OE, Augspurger ME, Schefter TE, Katz AW, Fisher BJ, Henke LE, Narayan S, Crane CH. Kachnic LA, et al. Among authors: augspurger me. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):146-157. doi: 10.1016/j.ijrobp.2021.08.008. Epub 2021 Aug 14. Int J Radiat Oncol Biol Phys. 2022. PMID: 34400269 Free PMC article. Clinical Trial.
Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529.
Kharofa JR, Yothers G, Kachnic LA, Ajani J, Meyer JE, Augspurger ME, Okawara GS, Garg MK, Schefter TE, Swanson TA, Doncals DE, Kim H, Zaki BI, Narayan S, Lee RJ, Mamon HJ, Schwartz MA, Moughan J, Crane CH. Kharofa JR, et al. Among authors: augspurger me. Am J Clin Oncol. 2022 Dec 1;45(12):534-536. doi: 10.1097/COC.0000000000000955. Epub 2022 Nov 22. Am J Clin Oncol. 2022. PMID: 36413683 Free PMC article.
Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy.
Tino R, Roach MA, Fuentes GD, Agrawal A, Zaid M, Cooper DJ, Bajaj N, Lin R, Xiao L, Mayo LL, Wiederhold LR, Shah SJ, Tate MK, Chronowski GM, Reddy JP, Mezera M, Mann JM, Augspurger M, Otun AO, Chambers MS, Koay EJ. Tino R, et al. Oral Oncol. 2024 Oct;157:106944. doi: 10.1016/j.oraloncology.2024.106944. Epub 2024 Jul 17. Oral Oncol. 2024. PMID: 39024700 Free article. Clinical Trial.
Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer.
Teh BS, Mai WY, Augspurger ME, Uhl BM, McGary J, Dong L, Grant WH 3rd, Lu HH, Woo SY, Carpenter LS, Chiu JK, Butler EB. Teh BS, et al. Among authors: augspurger me. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):465-72. doi: 10.1016/s0360-3016(00)01474-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11173142
Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
Floyd NS, Woo SY, Teh BS, Prado C, Mai WY, Trask T, Gildenberg PL, Holoye P, Augspurger ME, Carpenter LS, Lu HH, Chiu JK, Grant WH 3rd, Butler EB. Floyd NS, et al. Among authors: augspurger me. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):721-6. doi: 10.1016/S0360-3016(03)01623-7. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967426
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP. Glass J, et al. J Clin Oncol. 2016 May 10;34(14):1620-5. doi: 10.1200/JCO.2015.64.8634. Epub 2016 Mar 28. J Clin Oncol. 2016. PMID: 27022122 Free PMC article. Clinical Trial.
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy.
Magliocco AM, Moughan J, Miyamoto DT, Simko J, Shipley WU, Gray PJ, Hagan MP, Parliament M, Tester WJ, Zietman AL, McCarthy S, Saeed-Vafa D, Xiong Y, Ayral T, Hartford AC, Patel A, Rosenthal SA, Chafe S, Greenberg R, Schwartz MA, Augspurger ME, Keech JA Jr, Winter KA, Feng FY, Efstathiou JA. Magliocco AM, et al. Among authors: augspurger me. JAMA Netw Open. 2022 Nov 1;5(11):e2242378. doi: 10.1001/jamanetworkopen.2022.42378. JAMA Netw Open. 2022. PMID: 36383379 Free PMC article.
11 results